NCT02486094View on ClinicalTrials.gov

Study of PRoliferation and Apoptosis in Rectal Cancer, Predictive & Prognostic biOmarkers: Histopathology and Imaging

CompletedOBSERVATIONAL
Enrollment

148

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 1, 2016

Study Completion Date

June 7, 2017

Conditions
NeoplasmsColorectal NeoplasmsRectal DiseasesGastrointestinal Neoplasms
Trial Locations (1)

SM2 5PT

Royal Marsden Hospital NHS Foundation Trust, Sutton

All Listed Sponsors
collaborator

The Royal College of Surgeons of England

OTHER

collaborator

Croydon Health Services NHS Trust

OTHER

lead

Royal Marsden NHS Foundation Trust

OTHER

NCT02486094 - Study of PRoliferation and Apoptosis in Rectal Cancer, Predictive & Prognostic biOmarkers: Histopathology and Imaging | Biotech Hunter | Biotech Hunter